Page 1

tsmc TSMC Reports Third Quarter EPS of NT $ 6.03 Hsinchu , Taiwan , R.O.C. , Oct. 14 , 2021 – TSMC ( TWSE : 2330 , NYSE : TSM ) today announced consolidated revenue of NT $ 414.67 billion , net income of NT $ 156.26 billion , and diluted earnings per share of NT $ 6.03 ( US $ 1.08 per ADR unit ) for the third quarter ended September 30 , 2021 . Year - over - year , third quarter revenue increased 16.3 % while net income and diluted EPS both increased 13.8 % . Compared to second quarter 2021 , third quarter results represented a 11.4 % increase in revenue and a 16.3 % increase in net income . All figures were prepared in accordance with TIFRS on a consolidated basis . In US dollars , third quarter revenue was $ 14.88 billion , which increased 22.6 % year - over - year and increased 12.0 % from the previous quarter . Gross margin for the quarter was 51.3 % , operating margin was 41.2 % , and net profit margin was 37.7 % . In the third quarter , shipments of 5 - nanometer accounted for 18 % of total wafer revenue ; 7- nanometer accounted for 34 % . Advanced technologies , defined as 7 - nanometer and more advanced technologies , accounted for 52 % of total wafer revenue . “ Our third quarter business was mainly supported by strong demand across all four growth platforms , which are smartphone , HPC , IoT and Automotive - related applications , " said Wendell Huang , VP and Chief Financial Officer of TSMC . “ Moving into fourth quarter 2021 , we expect our business to be supported by strong demand for our industry - leading 5nm technology . ” Based on the Company's current business outlook , management expects the overall performance for fourth quarter 2021 to be as follows : Revenue is expected to be between US $ 15.4 billion and US $ 15.7 billion ; And , based on the exchange rate assumption of 1 US dollar to 28.0 NT dollars , Gross profit margin is expected to be between 51 % and 53 % ; Operating profit margin is expected to be between 39 % and 41 % . The above guidance includes expenses related to TSMC's donation of vaccines , which impacts operating margin by approximately one percentage point in the fourth quarter .